eXmoor pharma
We are eXmoor, a leading technical and strategic consultancy specialising in cell and gene therapies (ATMPs) and biopharmaceuticals.
Latest Content
Product News
eXmoor Pharma and Siam Bioscience Form Strategic Partnership To Establish Leading Cell and Gene Therapy Services in Southeast Asia
eXmoor and Siam Bioscience partner to build Thailand’s leading CGT hub, boosting regional innovation and patient access.
Product News
eXmoor and Virica Receive Funding To Improve AAV Gene Therapy Manufacturing
eXmoor pharma, and Virica Biotech Inc. (“Virica”), announced a new project funded in part through a joint Canada-UK government biomanufacturing collaboration.
Product News
Quell Therapeutics Expands Manufacturing Capabilities for CAR-Treg Cell Therapy Pipeline Through Partnership With eXmoor Pharma
Quell Therapeutics Ltd (“Quell” or “the Company”), and eXmoor pharma (“eXmoor”), announce a strategic partnership for the manufacture of multiple autologous engineered CAR-Treg cell therapies in Quell’s pipeline targeting autoimmune diseases.
Advertisement
